BioCryst, Idera merging

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) said it will merge with Idera Pharmaceuticals Inc. (NASDAQ:IDRA) to form a company focused on rare diseases. The combined company will be renamed when the merger closes, which is expected in

Read the full 355 word article

User Sign In